EPCAM and lung carcinoma: The first study by Rabinowits et al. [65], (published two years after the paper by Valadi et al. highlighting the role of EVs in transferring functional mRNAs and miRNAs [6]) used EpCAM immunoaffinity capture to purify for EVs present in the plasma of patients with lung cancer.